Results 141 to 150 of about 25,663 (196)

Accurate and Sensitive UHPLC-Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma. [PDF]

Pharmaceutics
Trozzi I, Giorgi B, De Paola R, Gatti M, Pea F.   +4 more
europepmc   +1 more source

Cefiderocol nonsusceptibility among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i>: data from the 2024 Antimicrobial Testing Leadership and Surveillance (ATLAS) program. [PDF]

Antimicrob Agents Chemother
Chiu P-W, Wang J-L, Hsueh S-C, Lee N-Y, Huang Y-T, Ko W-C, Hsueh P-R.   +6 more
europepmc   +1 more source

Comparison of agar-based methodologies to broth disc elution for the detection of aztreonam susceptibility in the presence of ceftazidime-avibactam. [PDF]

Microbiol Spectr
Sandstrom TS, Banete A, Kanyua A, Davis KM, Poutanen SM.   +4 more
europepmc   +1 more source

Postsurgical infection with carbapenemase-producing Enterobacterales in a 45-year-old woman. [PDF]

CMAJ
Leung E, Fattouh R, Verway M, Tan C.
europepmc   +1 more source

The <i>in vitro</i> activity of aztreonam-avibactam and cefiderocol against globally collected clinical metallo-β-lactamase- and/or serine-carbapenemase-positive Enterobacterales isolates and the utility of commonly used <i>in vitro</i> diagnostic kits. [PDF]

Microbiol Spectr
Estabrook M, Streit C, Townsend A, Stone G, Kamat S, Sahm D.   +5 more
europepmc   +1 more source

Susceptibility to novel antimicrobial agents and molecular epidemiology of carbapenem-resistant enterobacterales: a 9-year study in Central China. [PDF]

BMC Microbiol
Han Y, Wang Q, Chen H, Li Z, Wang Y, Zhao Y, Xia S, He W, Qiu X, Chen H, Li J, Yuan Y, Wang W.   +12 more
europepmc   +1 more source

Cefiderocol Heteroresistance in NDM-Producing Enterobacterales: A Complex Polymicrobial Infection Successfully Salvaged With Ceftazidime-Avibactam Plus Aztreonam. [PDF]

Am J Case Rep
Nuaimi M, Cirillo J, Usbosy S, Egan D, Kovacich A, Madruga M, Carlan SJ.   +6 more
europepmc   +1 more source

Impact of Susceptibility Testing Methodology on the Positioning of Cefiderocol and Aztreonam-Avibactam Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria. [PDF]

Antibiotics (Basel)
Del Nogal-Labrador F, González-Blanco B, Sanz MI, Recio R, Brañas P, Muñoz-Gallego I, Viedma E, Villa J.   +7 more
europepmc   +1 more source

Comparative <i>in vitro</i> efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. [PDF]

Antimicrob Agents Chemother
Emeraud C, Dutkiewicz M, Dortet L.
europepmc   +1 more source